Llwytho...
User preference for a portable syringe pump for iloprost infusion
PURPOSE: Administration of intravenous iloprost – a first-line European League Against Rheumatism (EULAR)-recommended choice for the treatment of scleroderma (SSc)-related digital vasculopathy – requires repeated treatment cycles of 6 hours per day in a hospital setting. During the infusion, patient...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Patient Relat Outcome Meas |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4447001/ https://ncbi.nlm.nih.gov/pubmed/26056502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S81473 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|